Evidence map›Paper›PMID 33650490›Full record

ArticleeLife2021

Genomic epidemiology of COVID-19 in care homes in the east of England.

William L Hamilton, Gerry Tonkin-Hill, Emily R Smith, Dinesh Aggarwal, Charlotte J Houldcroft, Ben Warne, Luke W Meredith, Myra Hosmillo, Aminu S Jahun, Martin D Curran and 28 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  10. Article
  11. Article
  12. The need for linked genomic surveillance of SARS-CoV-2.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 6 institutions in 1 country.

William L Hamilton *Cambridge University Hospitals NHS Foundation Trust, Departments of Infectious Diseases and Microbiology, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-3330-353X
Gerry Tonkin-Hill *Wellcome Sanger Institute, Hinxton, United Kingdom.ORCID https://orcid.org/0000-0003-4397-2224
Emily R SmithCambridgeshire County Council, Cambridge, United Kingdom.
Dinesh AggarwalUniversity of Cambridge, Department of Medicine, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-5938-8172
Charlotte J HouldcroftUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-1833-5285
Ben WarneCambridge University Hospitals NHS Foundation Trust, Departments of Infectious Diseases and Microbiology, Cambridge, United Kingdom.
Luke W MeredithUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.
Myra HosmilloUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-3514-7681
Aminu S JahunUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-4585-1701
Martin D CurranPublic Health England Clinical Microbiology and Public Health Laboratory, Cambridge, United Kingdom.
Surendra ParmarPublic Health England Clinical Microbiology and Public Health Laboratory, Cambridge, United Kingdom.
Laura G CallerUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.
Sarah L CaddyUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-9790-7420
Fahad A KhokharUniversity of Cambridge, Department of Medicine, Cambridge, United Kingdom.
Anna YakovlevaUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.
Grant HallUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0003-3928-3979
Theresa FeltwellUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.
Malte L PinckertUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.
Iliana GeorganaUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-8976-1177
Yasmin ChaudhryUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.
Colin S BrownPublic Health England, Colindale, United Kingdom.
Sonia GonçalvesWellcome Sanger Institute, Hinxton, United Kingdom.
Roberto AmatoWellcome Sanger Institute, Hinxton, United Kingdom.
Ewan M HarrisonWellcome Sanger Institute, Hinxton, United Kingdom.
Nicholas M BrownCambridge University Hospitals NHS Foundation Trust, Departments of Infectious Diseases and Microbiology, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-6657-300X
Mathew A BealeWellcome Sanger Institute, Hinxton, United Kingdom.ORCID http://orcid.org/0000-0002-4740-3187
Michael Spencer ChapmanWellcome Sanger Institute, Hinxton, United Kingdom.ORCID http://orcid.org/0000-0002-5320-8193
David K JacksonWellcome Sanger Institute, Hinxton, United Kingdom.ORCID http://orcid.org/0000-0002-8090-9462
Ian JohnstonWellcome Sanger Institute, Hinxton, United Kingdom.
Alex AldertonWellcome Sanger Institute, Hinxton, United Kingdom.
John SillitoeWellcome Sanger Institute, Hinxton, United Kingdom.
Cordelia LangfordWellcome Sanger Institute, Hinxton, United Kingdom.
Gordon DouganUniversity of Cambridge, Department of Medicine, Cambridge, United Kingdom.
Sharon J PeacockUniversity of Cambridge, Department of Medicine, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-1718-2782
Dominic P KwiatowskiWellcome Sanger Institute, Hinxton, United Kingdom.
Ian G GoodfellowUniversity of Cambridge, Department of Pathology, Division of Virology, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-9483-510X
M Estee TorokCambridge University Hospitals NHS Foundation Trust, Departments of Infectious Diseases and Microbiology, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-9098-8590
COVID-19 Genomics Consortium UK
University of Cambridge · GBWellcome Sanger Institute · GBPublic Health England · GBCambridgeshire County Council · GBCambridge University Hospitals NHS Foundation Trust · GBImperial College Healthcare NHS Trust · GB

Funding

Academy of Medical Sciences Clinician Scientist FellowshipAcademy of Medical Sciences Clinician Scientist Fellowship to METMedical Research Council COG-UK grant to SJPMedical Research Council COG-UK MC-PC-19027Medical Research Council MC_PC_19027Medical Research Council MR/N029399/1Wellcome Trust COG-UK MC-PC-19027Wellcome Trust Collabrative grant 204870/Z/16/ZWellcome Trust Senior Fellowship 097997/Z/11/Z
6 · The paper itself

Abstract

COVID-19 poses a major challenge to care homes, as SARS-CoV-2 is readily transmitted and causes disproportionately severe disease in older people. Here, 1167 residents from 337 care homes were identified from a dataset of 6600 COVID-19 cases from the East of England. Older age and being a care home resident were associated with increased mortality. SARS-CoV-2 genomes were available for 700 residents from 292 care homes. By integrating genomic and temporal data, 409 viral clusters within the 292 homes were identified, indicating two different patterns - outbreaks among care home residents and independent introductions with limited onward transmission. Approximately 70% of residents in the genomic analysis were admitted to hospital during the study, providing extensive opportunities for transmission between care homes and hospitals. Limiting viral transmission within care homes should be a key target for infection control to reduce COVID-19 mortality in this population.

Indexed as

Nursing HomesAged, 80 and overCOVID-19Disease OutbreaksEnglandFemaleHumansInfectious Disease Transmission, Patient-to-ProfessionalInfectious Disease Transmission, Professional-to-PatientMalePolymorphism, Single NucleotideSARS-CoV-2Sequence AnalysisTime FactorsCOVID-19epidemiologygeneticsgenomicsglobal healthSARS-CoV-2virus

Identifiers

PMID33650490
PMCPMC7997667
OpenAlexW3133494578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.